Members |
targetComponentId |
Secondary non-infected iridocyclitis |
Secondary noninfectious iridocyclitis (disorder) |
Secondary operation NOC |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
Secondary osteosarcoma |
Secondary osteosarcoma is an osteosarcoma that arises secondarily in a precursor disease of the bone such as Paget disease, chronic osteomyelitis, fibrous dysplasia and other benign bone conditions or post-treatment, for example, following chemotherapy or therapeutic radiotherapy. |
Secondary syphilis of other viscera |
Secondary syphilis of viscera |
Secondary teacher NOS |
Secondary education teacher |
Secondary teacher NOS |
Secondary education teacher |
Secondary transvestism |
Secondary transvestism (finding) |
Secondary uterine inertia with antenatal problem |
Secondary uterine inertia |
Secondary/other glaucoma |
Secondary glaucoma |
Secondary/other glaucoma |
Secondary glaucoma |
Secretary:shorthand/typing NOS |
Secretaries: shorthand/typing |
Secretary:shorthand/typing NOS |
Secretaries: shorthand/typing |
Secretin 40mcg powder for injection solution vial |
Product containing only secretin in parenteral dose form (medicinal product form) |
Secretory otitis media |
Chronic mucoid otitis media |
Sedating antihistamine |
Histamine receptor antagonist |
Sedating antihistamine adverse reaction |
Adverse reaction to antihistamines |
Sedative agent |
Sedative (substance) |
Sedative dependence |
Sedative dependence (disorder) |
Sedative dependence with current use |
Sedative dependence (disorder) |
Sedative withdrawal syndrome without complication |
Sedative withdrawal |
Seen in other clinic |
Seen in clinic |
Seen in other clinic |
Seen in clinic |
Seizure co-occurrent and due to drug withdrawal |
Seizure co-occurrent and due to substance withdrawal |
Seizure disorder clinical management plan |
Seizure disorder clinical management plan |
Seizure free > 12 months |
Seizure free (finding) |
Seizure undetermined whether focal or generalized |
A transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain, regardless of whether focal, generalized, or unknown onset, whether aware or impaired awareness, and whether motor or nonmotor. |
Sejongia antarctica |
Chryseobacterium antarcticum (organism) |
Sejongia jeonii |
Chryseobacterium jeonii (organism) |
Selective angiocardiography |
Fluoroscopic selective angiocardiography with contrast (procedure) |
Selective bronchography |
Fluoroscopic selective bronchography with contrast |
Selective bronchography |
Fluoroscopic selective bronchography with contrast |
Selective extracranial vagotomy NEC |
Selective vagotomy |
Selegiline 1.25mg orally disintegrating tablet |
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Selegiline 12mg/24hours transdermal patch |
Selegiline 500 microgram/hour prolonged-release transdermal patch |
Selegiline 6mg/24hours transdermal patch |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Selegiline 9mg/24hours transdermal patch |
Selegiline 375 microgram/hour prolonged-release transdermal patch |
Selenium 100micrograms/2mL oral solution |
Product containing only selenium in oral dose form (medicinal product form) |
Selenium 100micrograms/2mL solution for injection |
Product containing only selenium in parenteral dose form (medicinal product form) |
Selenium 500micrograms/10mL oral solution |
Product containing only selenium in oral dose form (medicinal product form) |
Selenium 500micrograms/10mL solution for injection |
Product containing only selenium in parenteral dose form (medicinal product form) |
Self poisoning by agricultural chemical |
Self poisoning by herbicide (disorder) |
Self poisoning by non-drug solid or liquid agents |
Self-administered poisoning |
Self-induced abortion |
Self-induced termination of pregnancy |
Self-induced abortion |
Self-induced termination of pregnancy |
Self-referral to hospital NOS |
Self-referral to hospital |
Self-referral to hospital NOS |
Self-referral to hospital |
Semen exam.: general NOS |
Semen analysis |
Semen examination NOS |
Semen analysis |
Semen examination NOS |
Semen analysis |
Semen examination: general NOS |
Semen analysis |
Seminoma - category |
Malignant seminoma |
Seminoma, no International Classification of Diseases for Oncology subtype |
Malignant seminoma |
Senile dermatitis herpetiformis |
Dermatitis herpetiformis |
Senile dermatitis herpetiformis |
Dermatitis herpetiformis |
Senna |
Cassia acutifolia |
Senna 7.5mg/5mL s/f syrup |
Senna only product in oral dose form |
Senna 7.5mg/5mLconventional release oral syrup |
Senna only product in oral dose form |
Senna+ispaghula 12.4%/54.2% granules |
Psyllium and senna only product |
Sensory nerve conduction study for velocity and/or latency |
Sensory nerve conduction study (procedure) |
Sensory skin flap NOS |
Sensory skin flap |
Sensory symptom NOS |
Sensory symptoms |
Sensory symptom NOS |
Sensory symptoms |
Sentinel node |
Sentinel lymph node |
Separation of siamese twins |
Separation of conjoined twins |
Sepsis during labor with antenatal problem |
Sepsis during labor (disorder) |
Sepsis-associated encephalopathy |
Encephalopathy with sepsis |
Sepsis-associated gastrointestinal hemorrhage |
Gastrointestinal hemorrhage with sepsis |
Sepsis-associated left ventricular failure |
Left ventricular failure with sepsis |
Sepsis-associated lung injury |
Lung injury with sepsis |
Sepsis-associated myocardial dysfunction |
Myocardial dysfunction with sepsis (disorder) |
Sepsis-associated right ventricular failure |
Right ventricular failure with sepsis |
Sepsis-related gastritis |
Gastritis with sepsis |
Sepsis-related gastrointestinal lesions |
Gastrointestinal lesion with sepsis |
Sepsis-related gastrointestinal ulceration |
Gastrointestinal ulceration due to sepsis |
Septal cartilage nose sprain |
Injury of nasal septum |
Septal defect NOS |
Cardiac septal defects |
Septal defect NOS |
Cardiac septal defects |
Septata |
Encephalitozoon (organism) |
Septate vagina affecting obstetric care |
Septate vagina in pregnancy, childbirth and the puerperium (disorder) |
Septate vagina in pregnancy, childbirth or the puerperium NOS |
Septate vagina in pregnancy, childbirth and the puerperium (disorder) |
Septicemia caused by Bacteroides |
Sepsis caused by Bacteroides (disorder) |
Septoplasty unspecified |
Nasal septoplasty (procedure) |
Septoplasty unspecified |
Nasal septoplasty (procedure) |
Sequelae of disorders by system of sequelae |
Disease |
Sequelae of disorders classified by disorder-system |
Sequelae of disorders (disorder) |
Sequelae of other non-traumatic intracranial haemorrhage |
Sequelae of neurological disorders |
Sequelae of other non-traumatic intracranial hemorrhage |
Sequelae of neurological disorders |
Serial radiography of lungs |
Serial plain X-ray of chest (procedure) |
Serial radiography of lungs |
Serial plain X-ray of chest (procedure) |
Serogroup Rift Valley Fever |
Sandfly fever Naples virus |
Serogroup Sandfly Naples |
Sandfly fever Naples virus |
Serogroup Sandfly Sicily |
Sandfly fever Sicilian virus (organism) |
Serology: organism (& [bacteria] or [fungus] or [parasite] or [virus]) |
Specific antibody level - finding |
Serology: organism (& [bacteria] or [fungus] or [parasite] or [virus]) |
Specific antibody level - finding |
Serology: organism NOS |
Serologic test |
Serology: organism NOS |
Serologic test |
Serotonin uptake inhibitor |
Selective serotonin re-uptake inhibitor |
Serous blood |
Serous discharge (substance) |
Serous cystadenoma, borderline malignancy |
Serous cystadenoma, borderline malignancy |
Serous surface papillary carcinoma |
Serous cystadenocarcinoma |
Serratus anterior myocutaneous flap plus rib |
Serratus anterior osteomyocutaneous flap of rib (substance) |